Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

4.7%

2 terminated/withdrawn out of 43 trials

Success Rate

95.3%

+8.8% vs industry average

Late-Stage Pipeline

21%

9 trials in Phase 3/4

Results Transparency

15%

6 of 41 completed trials have results

Key Signals

6 with results

Enrollment Performance

Analytics

Phase 1

16(37.2%)

N/A

15(34.9%)

Phase 3

5(11.6%)

Phase 4

4(9.3%)

Phase 2

2(4.7%)

Early Phase 1

1(2.3%)

43Total

Phase 1(16)

N/A(15)

Phase 3(5)

Phase 4(4)

+2 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (43)

Showing 20 of 43 trials

NCT05182047Phase 1Withdrawn

A Study of Butamirate Citrate Syrup Versus (vs) Sinecod Syrup (Vanilla) in Adult Healthy Study Volunteers

Role: lead

NCT04186936Phase 1Completed

A Study of Combination Caplet With Loperamide Hydrochloride and Simethicone, and Imodium Express Tablets-lyophilizate Coadministered With Espumisan Capsule in Healthy Volunteers

Role: lead

NCT03697889Phase 1Completed

A Study to Assess Bioquivalence Between a Novel Naproxen Sodium 275 mg Film-coated Tablet and Nalgesin Naproxen Sodium 275 mg Film-coated Tablet in Healthy Adult Volunteers

Role: lead

NCT02355665Phase 3Completed

Study to Determine the Efficacy and Safety of a Novel Nicotine Replacement Therapy

Role: collaborator

NCT03259607Phase 1Completed

Clinical Study to Assess Bioequivalence Between Nicorette Extra Mint Gum and Nicorette® Mint Gum in Healthy Smokers

Role: lead

NCT03439436Phase 3Completed

A Study to Compare Two Formulations of Xylometazoline/Dexpanthenol Nasal Spray for the Treatment of Nasal Congestion.

Role: lead

NCT03432923Phase 3Completed

A Study to Determine the Efficacy and Safety of a Benzocaine Lozenge for Treatment of Sore Throat.

Role: lead

NCT03130179Phase 1Completed

A Bioequivalence Study Between Two Nicotine Replacement Therapies in Adult Healthy Smokers Motivated to Quit.

Role: lead

NCT01084707Not ApplicableCompleted

Multiple-dose Nicotine Pharmacokinetics With a New Oral Nicotine Replacement Product.

Role: lead

NCT01238640Not ApplicableCompleted

Bioequivalence Between Two New Oral Nicotine Replacement Therapy Products and Nicorette® Microtab

Role: lead

NCT00749463Phase 4Completed

Evaluation of the Safety Profile, Quit and Reduction Rate After Nicorette® Gum and Patch Treatment

Role: lead

NCT01084603Not ApplicableCompleted

Single-dose Nicotine Pharmacokinetics With a New Oral Nicotine Replacement Product

Role: lead

NCT00378144Phase 4Completed

Efficacy and Safety of Sinutab on Subjects in the Setting of a Common Cold

Role: lead

NCT01302093Phase 1Completed

Bioequivalence Between a Racecadotril Capsule and Film-Coated Tablet (FCT) to Treat Diarrhea in Adults

Role: lead

NCT01112462Phase 1Completed

To Test Bioequivalence Between Two Formulations of Paracetamol/Phenylephrine

Role: lead

NCT01555476Phase 1Completed

Study to Test the Blood to See if a New Medicine is Likely to Provide Pain Relief Similar to a Product Already Sold in Stores

Role: lead

NCT01234896Not ApplicableCompleted

Single-dose Nicotine Pharmacokinetics With Four Oral Nicotine Replacement Products

Role: lead

NCT01238627Not ApplicableCompleted

Bioequivalence Between Two Oral Nicotine Sublingual Tablets, 2 mg and 4 mg

Role: lead

NCT01152723Not ApplicableCompleted

Pharmacokinetics With Two New Oral Nicotine Replacement Products and Nicorette® Gum

Role: lead

NCT01075659Phase 2Completed

Early Effects of a New Oral Nicotine Replacement Product and NiQuitin™ Lozenge

Role: lead